Delivery Order SPE2DB20D1109-SPE2DB24FN05C

Award Date 11/8/23
Potential Completion Date 11/9/23
Potential Value $2.7K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,206.73 firm fixed-price delivery order is for the supply of 4566749106 - Clindamycin Phosphate 1% Foam, 100 grams. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,310.66 Delivery Order contract is for the supply of Clindamycin Phosphate 1% Foam, a pharmaceutical product, with a completion date of November 7, 2024. The contract has a Firm Fixed Price pricing type and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the delivery of clindamycin phosphate 1% foam in 50g units. The contract has a ceiling value of $1,173.91 and a completion date of June 25, 2024. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,140.36 firm fixed-price contract is for the supply of 100 gram containers of 1% clindamycin phosphate foam. The order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support U.S. military...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4563335833 - Clindamycin Phosphate 1% Foam, 50 grams. The contract has a ceiling value of $1,568.55 and an ultimate completion date of January 17, 2024. This is a firm-fixed-price contract without any set-aside designations, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMHLH, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,506.14 firm fixed price delivery order is for the supply of 4567174426 - Clindamycin Phosphate 1% Foam, 100GM. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,173.74 firm fixed-price contract is for the supply of Clindamycin Phosphate 1% Foam, a topical antibiotic medication. The contract has a period of performance through November 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation, to provide Clindamycin Phosphate 1% Foam in 100 gram units. The $3,572.64 contract has a completion date of February 26, 2024 and was awarded on February 23, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will deliver the pharmaceutical product from its corporate office location...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Clindamycin Phosphate 1% Foam, 100 gm. The contract has a ceiling value of $6,681.59 and an ultimate completion date of April 26, 2023. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of Clindamycin Phosphate 1% Foam, 50 grams, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,876.56 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, as part of an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 with the DLA through December 2025. The contract does not have a set-aside designation. This award is for the supply of critical pharmaceutical...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FN05C
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of Clindamycin Phosphate 1% Foam, a medical product, with a ceiling value of $2,706.08 and an ultimate completion date of November 9, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. The contract award does not have a set-aside designation, indicating it was awarded through full and open competition.

Generated 5/12/25, 9:52 AM